Clinical Trial Update: Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating zoledronic acid in patients with multiple myeloma and asymptomatic biochemical relapse has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Multiple Myeloma | Phase 4 | Status: COMPLETED